Two siblings with an IL-12 and IFN-γ production disorder diagnosed with pulmonary mycobacteriosis caused by M. kansasii. Mendelian susceptibility to mycobacterial infection. An overview of literature;Mykobakterioza płuc wywolana przez M. kansasii u dwojga rodzeństwa z zaburzeniami produkcji IL-12 i IFN-γ. Zespół wrazliwości typu Mendla na zakazenie prątkami. Przegląd piśmiennictwa

Pneumonologia i Alergologia Polska

Volumn 79, Issue 6, 2011, Pages 428-436

  Nalepa, Piotr ^a   Strach, Magdalena ^b   Rybak Bak, Marta ^a   Siedlar, Maciej ^b  

^a II Oddzial Chorob Pluc   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Diagnosis; Mendelian susceptibility to mycobacterial infection; Mycobacterial infection; Treatment

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ADULT; ATYPICAL MYCOBACTERIOSIS; BIOSYNTHESIS; CASE REPORT; FEMALE; GENETIC PREDISPOSITION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MYCOBACTERIUM KANSASII; POLAND; REVIEW; SIBLING;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; POLAND; SIBLINGS; YOUNG ADULT;

EID: 80055118552     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Griffith D.E., Aksamit T., Brown-Elliot B.A. i wsp. An official ATS/IDSA statement: Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007; 175: 367-416.
2. Daley C.L., Heifets L. Other mycobacteria causing human disease. W: Schaaf H.S., Zumla A. (red.). Tuberculosis. Saunders, Philadelphia 2009; 60-74.
3. Runyon E.H. Anonymous mycobacteria in pulmonary disease. Med. Clin. North Am. 1959; 15: 201-208.
4. Glassroth J. Pulmonary disease due to nontuberculosis mycobacteria. Chest 2008; 133: 243-251.
5. Wilińska E., Szturmowicz M. Mikobakteriozy płuc-obraz kliniczny, diagnostyka i leczenie. Pneumonol. Alergol. Pol. 2010; 78: 138-147.
6. Sexton P., Harrison A.C. Susceptibility to nontuberculous mycobacterial lung disease. Eur. Respir. J. 2008; 31: 1322--1333.
7. Jones D., Havlir D.V. Nontuberculous mycobacteria in the HIV infected patient. Clin. Chest Med. 2002; 23: 665-674.
8. Cattamanchi A., Payam N., Marras T.K. i wsp. Detailed analysis of the radiografic presentation of Mycobacterium kansasii lung disease in patient with HIV infection. Chest 2008; 133: 875--880.
9. Rowińska-Zakrzewska E. Wybrane aspekty genetycznej podatności na gruźlice{ogonek}. Pneumonol. Alergol. Pol. 2005; 73: 193-197.
10. Colombo R.E., Hill S.C., Claypool R.J. i wsp. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2010; 137: 629-634.
11. King-Sun W., Tzou-Yen L., Yhu-chering H. i wsp. Nontuberculous mycobacterial pulmonary disease in an immunocompetent adolescent. Respir. Care 2008; 53: 908-911.
12. Henry M.T., Inamdar L., O'Riordain D. i wsp. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur. Respir. J. 2004; 23: 741-746.
13. Fieschi C. Mendelian susceptibility to mycobacterial disease: defects in the IL12/IFNgamma pathway. Press Med. 2006; 35: 879-886.
14. Holland S.M. Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection. Microbes Infect. 2000; 2: 1579-1590.
15. Cottle L.E. Mendelian susceptibility to mycobacterial disease. Clin. Genet. 2011; 79: 17-22.
16. Casanova J.L. Mendelian predisposition to mycobacterial infections in humans. J. Soc. Biol. 2000; 194: 25-28.
17. Newport M.J., Huxley C.M., Huston S. i wsp. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 1996; 335: 1941--1949.
18. Yancoski J., Rocco C., Bernasconi A. i wsp. A 475 years-old founder effect involving ILI12RB1: a highly prelegent mutation conferring Mendelian susceptibility to mycobacterial diseases in European descendants. Infect. Genet. Evol. 2009; 9: 574-580.
19. Bustamante J., Picard C., Fieschi C. i wsp. A novel X-linked recessive form of Mendelian susceptibility to mycobacterial disease. J. Med. Genet. 2007; 44: e65.
20. Grifffith D.E. Management of disease due to Mycobacterium kansasii. Clin. Chest Med. 2002; 23: 613-621.
21. Avnon Solling L., Gelfer E., Heimer D. Immunocompetent patients with pulmonary Mycobacterium kansasii infection: A case series and revive of the literature. Clin. Pulm. Med. 2003; 10: 131-135.
22. Winek J., Demkow U., Rowińska-Zakrzewska E. Odpowiedź Th1-Th2 u chorych na gruźlice{ogonek} oraz osób pozostaja{ogonek}cych z nimi w styczności. Pneumonol. Alergol. Pol. 2009; 77: 446--452.